• $101,095.00
    Market Cap
  • -97.98%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
398,151
-91.45%
4.7M
+33.70%
3.5M
+97.03%
1.8M
N/A
Cost of Revenue
295,589
-89.83%
2.9M
+27.33%
2.3M
+73.97%
1.3M
+1,321.20%
Gross Profit
238,295
-87.33%
1.9M
+56.25%
1.2M
+163.44%
456,793
+1,396.65%
Sales and Marketing Expense
41,954
-15.98%
49,932
+4,724.35%
1,035
-65.05%
2,961
-99.10%
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
467,326
+14.15%
409,398
+20.64%
339,369
+35.67%
250,144
+36.69%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
N/A
N/A
N/A
N/A
-701,215
-14.30%
-818,228
-52.10%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-701,215
-14.30%
-818,228
-52.10%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-701,215
-14.30%
-818,228
-52.10%
Basic EPS and Net Income
-0.02
+100.00%
-0.01
0.00%
-0.01
0.00%
-0.01
-50.00%
Diluted EPS and Net Income
-0.02
+100.00%
-0.01
0.00%
-0.01
0.00%
-0.01
-50.00%
Basic Weighted Average Shares
101.3M
+0.97%
100.3M
+0.76%
99.6M
+1.74%
97.9M
+5.67%
Diluted Weighted Average Shares
101.3M
+0.97%
100.3M
+0.76%
99.6M
+1.74%
97.9M
+5.67%
Balance Sheet
Cash and Cash Equivalents
227,918
-79.87%
1.1M
+309.44%
276,571
-55.43%
620,527
-69.17%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
227,918
-79.87%
1.1M
+309.44%
276,571
-55.43%
620,527
-69.17%
Total Current Assets
366,333
-76.86%
1.6M
+104.63%
773,561
-45.95%
1.4M
-33.71%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
196,789
-70.02%
656,441
-61.79%
1.7M
+55.05%
1.1M
+1,119.25%
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
563,125
-75.50%
2.3M
-9.44%
2.5M
-1.20%
2.6M
+12.61%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
173,561
-47.54%
330,817
-37.49%
529,218
-12.51%
604,893
+616.04%
Retained Earnings
-34.3M
+5.74%
-32.4M
+2.11%
-31.7M
+2.26%
-31.0M
+2.71%
Total Stockholders Equity
N/A
N/A
2.0M
-2.05%
2.0M
+2.29%
2.0M
-10.60%
Total Shares Outstanding
101.3M
0.00%
101.3M
+1.65%
99.6M
+0.40%
99.2M
+1.75%
Cash Flow
Cash from Operating Activities
-789,933
-178.63%
1.0M
+52.12%
660,403
+250.83%
-437,832
-64.52%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-114,362
-44.31%
-205,347
-80.38%
-1.0M
-13.38%
-1.2M
+760.99%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
56,600
+33.18%
42,500
-83.26%
253,880
-91.77%
Financials Ratio
Gross Margin
25.76%
-31.55%
37.63%
+9.03%
34.51%
+33.61%
25.83%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-27.46%
-18.61%
-33.74%
-73.12%
Return on Equity
N/A
N/A
N/A
N/A
-35.30%
-10.25%
-39.33%
-82.93%
Revenue Growth
-91.45%
-371.38%
33.70%
-65.27%
97.03%
N/A
N/A
N/A
Current Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow